FDA grants EUA for Visby Medical's COVID-19 test

2021 01 11 17 03 4617 Covid Diagnostic Test Kit 400

The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for Visby Medical's COVID-19 reverse transcription polymerase chain reaction test for pooled samples.

The authorization expands the company's first EUA for single-patient-sample testing to pooled testing of up to five samples at once for SARS-CoV-2, Visby said.

Page 1 of 34
Next Page